HomeCompareEGTTF vs MRK

EGTTF vs MRK: Dividend Comparison 2026

EGTTF yields 1052.63% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EGTTF wins by $29512389.22M in total portfolio value
10 years
EGTTF
EGTTF
● Live price
1052.63%
Share price
$0.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29512389.28M
Annual income
$24,865,533,772,207.38
Full EGTTF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EGTTF vs MRK

📍 EGTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEGTTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EGTTF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EGTTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EGTTF
Annual income on $10K today (after 15% tax)
$89,473.68/yr
After 10yr DRIP, annual income (after tax)
$21,135,703,706,376.27/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EGTTF beats the other by $21,135,703,698,047.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EGTTF + MRK for your $10,000?

EGTTF: 50%MRK: 50%
100% MRK50/50100% EGTTF
Portfolio after 10yr
$14756194.67M
Annual income
$12,432,766,891,002.76/yr
Blended yield
84.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EGTTF
No analyst data
Altman Z
142.7
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EGTTF buys
0
MRK buys
0
No recent congressional trades found for EGTTF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEGTTFMRK
Forward yield1052.63%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$29512389.28M$56.8K
Annual income after 10y$24,865,533,772,207.38$9,798.13
Total dividends collected$29159831.22M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EGTTF vs MRK ($10,000, DRIP)

YearEGTTF PortfolioEGTTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$115,963$105,263.16$11,206$366.19+$104.8KEGTTF
2$1,264,889$1,140,808.24$12,650$502.35+$1.25MEGTTF
3$12,982,935$11,629,504.04$14,407$694.19+$12.97MEGTTF
4$125,449,028$111,557,287.82$16,585$967.82+$125.43MEGTTF
5$1,141,645,861$1,007,415,400.94$19,342$1,363.89+$1141.63MEGTTF
6$9,789,747,608$8,568,186,536.38$22,913$1,947.19+$9789.72MEGTTF
7$79,141,579,327$68,666,549,386.16$27,662$2,823.89+$79141.55MEGTTF
8$603,475,154,069$518,793,664,189.69$34,159$4,173.35+$603475.12MEGTTF
9$4,342,855,615,350$3,697,137,200,495.55$43,337$6,308.80+$4342855.57MEGTTF
10$29,512,389,280,631$24,865,533,772,207.38$56,776$9,798.13+$29512389.22MEGTTF

EGTTF vs MRK: Complete Analysis 2026

EGTTFStock

EYEFI Group Technologies Inc., an electronics and software engineering company, develops spatial, predictive, approximation, and radial convolution (SPARC) technology. Its products include EYEfi Cloud, a platform that offers remote monitoring, intelligence gathering, and situational awareness solutions; EYEfi Sensors, which is used for monitoring and intelligence gathering applications from industrial-grade camera sensors; EYEfi SPARC, a situational awareness technology for government and industry; and EYEfi SPARC (mobile), a solution that spatially enables smartphones, wearable technology, and UAVs. The company's SPARC solution turns sensors, cameras, or smartphone devices (fixed, mobile, airborne, portable, or handheld) into target co-ordinate acquisition systems. Its solutions also include Industrial Internet of Things (IIoT) hardware sensor product and cloud application (Smart Waste) for waste bins and smart drain for storm water pits. The company, through resellers, serves government and industry customers in the infrastructure and asset management, emergency management, and incident response markets primarily in Australia and New Zealand. EYEFI Group Technologies Inc. was incorporated in 2018 and is headquartered in Collingwood, Australia.

Full EGTTF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EGTTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EGTTF vs SCHDEGTTF vs JEPIEGTTF vs OEGTTF vs KOEGTTF vs MAINEGTTF vs JNJEGTTF vs ABBVEGTTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.